Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV
Kalmanti, L, Saussele, S, Lauseker, M, Müller, M C, Dietz, C T, Heinrich, L, Hanfstein, B, Proetel, U, Fabarius, A, Krause, S W, Rinaldetti, S, Dengler, J, Falge, C, Oppliger-Leibundgut, E, Burchert, A, Neubauer, A, Kanz, L, Stegelmann, F, Pfreundschuh, M, Spiekermann, K, Scheid, C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R
Published in Leukemia (01.05.2015)
Published in Leukemia (01.05.2015)
Get full text
Journal Article
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
Pfirrmann, M, Baccarani, M, Saussele, S, Guilhot, J, Cervantes, F, Ossenkoppele, G, Hoffmann, V S, Castagnetti, F, Hasford, J, Hehlmann, R, Simonsson, B
Published in Leukemia (01.01.2016)
Published in Leukemia (01.01.2016)
Get full text
Journal Article
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
Hoffmann, V S, Baccarani, M, Hasford, J, Lindoerfer, D, Burgstaller, S, Sertic, D, Costeas, P, Mayer, J, Indrak, K, Everaus, H, Koskenvesa, P, Guilhot, J, Schubert-Fritschle, G, Castagnetti, F, Di Raimondo, F, Lejniece, S, Griskevicius, L, Thielen, N, Sacha, T, Hellmann, A, Turkina, A G, Zaritskey, A, Bogdanovic, A, Sninska, Z, Zupan, I, Steegmann, J-L, Simonsson, B, Clark, R E, Covelli, A, Guidi, G, Hehlmann, R
Published in Leukemia (01.06.2015)
Published in Leukemia (01.06.2015)
Get full text
Journal Article
The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies
Heldwein, W, Dollhopf, M, Rösch, T, Meining, A, Schmidtsdorff, G, Hasford, J, Hermanek, P, Burlefinger, R, Birkner, B, Schmitt, W
Published in Endoscopy (01.11.2005)
Published in Endoscopy (01.11.2005)
Get more information
Journal Article
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib
Hanfstein, B, Shlyakhto, V, Lauseker, M, Hehlmann, R, Saussele, S, Dietz, C, Erben, P, Fabarius, A, Proetel, U, Schnittger, S, Krause, S W, Schubert, J, Einsele, H, Hänel, M, Dengler, J, Falge, C, Kanz, L, Neubauer, A, Kneba, M, Stegelmann, F, Pfreundschuh, M, Waller, C F, Spiekermann, K, Baerlocher, G M, Pfirrmann, M, Hasford, J, Hofmann, W-K, Hochhaus, A, Müller, M C
Published in Leukemia (01.10.2014)
Published in Leukemia (01.10.2014)
Get full text
Journal Article
Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A, Hehlmann, R
Published in Leukemia (01.03.2017)
Published in Leukemia (01.03.2017)
Get full text
Journal Article
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis
Kuendgen, A, Lauseker, M, List, A F, Fenaux, P, Giagounidis, A A, Brandenburg, N A, Backstrom, J, Glasmacher, A, Hasford, J, Germing, U
Published in Leukemia (01.05.2013)
Published in Leukemia (01.05.2013)
Get full text
Journal Article
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
Miranda, M B, Lauseker, M, Kraus, M-P, Proetel, U, Hanfstein, B, Fabarius, A, Baerlocher, G M, Heim, D, Hossfeld, D K, Kolb, H-J, Krause, S W, Nerl, C, Brümmendorf, T H, Verbeek, W, Fauser, A A, Prümmer, O, Neben, K, Hess, U, Mahlberg, R, Plöger, C, Flasshove, M, Rendenbach, B, Hofmann, W-K, Müller, M C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R, Saußele, S
Published in Leukemia (01.06.2016)
Published in Leukemia (01.06.2016)
Get full text
Journal Article
Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients
Schmiedl, S, Rottenkolber, M, Szymanski, J, Drewelow, B, Siegmund, W, Hippius, M, Farker, K, Guenther, I R, Hasford, J, Thuermann, P A
Published in Expert opinion on drug safety (01.02.2018)
Published in Expert opinion on drug safety (01.02.2018)
Get more information
Journal Article
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
GERMING, U, LAUSEKER, M, MACIEJEWSKI, J, HAASE, D, SCHANZ, J, SEYMOUR, J, KENEALY, M, WEIDE, R, LÜBBERT, M, LATZBECKER, U. P, VALENT, P, GÖTZE, K, HILDEBRANDT, B, STAUDER, R, BLUM, S, KREUZER, K.-A, SCHLENK, R, GANSER, A, HOFMANN, W.-K, AUL, C, KRIEGER, O, KÜNDGEN, A, HAAS, R, SYMEONIDIS, A, HASFORD, J, GIAGOUNIDIS, A, CERMAK, J, FENAUX, P, KELAIDI, C, PFEILSTÖCKER, M, NÖSSLINGER, T, SEKERES, M
Published in Leukemia (01.06.2012)
Published in Leukemia (01.06.2012)
Get full text
Journal Article
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany
ROHRBACHER, M, BERGER, U, HEHLMANN, R, HOCHHAUS, A, METZGEROTH, G, ADAM, K, LAHAYE, T, SAUSSELE, S, MÜLLER, M. C, HASFORD, J, HEIMPEL, H
Published in Leukemia (01.03.2009)
Published in Leukemia (01.03.2009)
Get full text
Journal Article
In-hospital fall-risk screening in 4,735 geriatric patients from the LUCAS project
Neumann, L, Hoffmann, V. S, Golgert, S, Hasford, J, von Renteln-Kruse, Wolfgang
Published in The Journal of nutrition, health & aging (01.03.2013)
Published in The Journal of nutrition, health & aging (01.03.2013)
Get full text
Journal Article
Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed
Hasford, J, Bramlage, P, Koch, G, Lehmacher, W, Einhäupl, K, Rothwell, P.M
Published in Journal of clinical epidemiology (01.12.2010)
Published in Journal of clinical epidemiology (01.12.2010)
Get full text
Journal Article
Erythropoietin-induced treatment costs in patients suffering from renal anemia - a comparison between biosimilar and originator drugs
Hörbrand, F, Rottenkolber, D, Fischaleck, J, Hasford, J
Published in Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) (01.11.2014)
Published in Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) (01.11.2014)
Get more information
Journal Article
A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction
Afonso, A., Schmiedl, S., Becker, C., Tcherny-Lessenot, S., Primatesta, P., Plana, E., Souverein, P., Wang, Y., Korevaar, J. C., Hasford, J., Reynolds, R., de Groot, M. C. H., Schlienger, R., Klungel, O., Rottenkolber, M.
Published in European journal of clinical pharmacology (01.09.2016)
Published in European journal of clinical pharmacology (01.09.2016)
Get full text
Journal Article